Hepatitis C Fact sheet. World Health Organization http://www.who.int/mediacentre/factsheets/fs164/en/ (2024).
Torrents de la Pena, A. et al. Structure of the hepatitis C virus E1E2 glycoprotein complex. Science 378, 263â269 (2022).
Law, J. L. et al. A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS ONE 8, e59776 (2013).
Duncan, J. D., Urbanowicz, R. A., Tarr, A. W. & Ball, J. K. Hepatitis C virus vaccine: challenges and prospects. Vaccines 8, 90 (2020).
Capella-Pujol, J. et al. Signatures of VH1â69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins. Nat. Commun. 14, 4036 (2023).
Freedman, H. et al. Computational prediction of the heterodimeric and higher-order structure of gpE1/gpE2 envelope glycoproteins encoded by hepatitis C virus. J. Virol. 91, e02309âe02316 (2017).
Falson, P. et al. Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion. J. Virol. 89, 10333â10346 (2015).
Gerold, G., Moeller, R. & Pietschmann, T. Hepatitis C virus entry: protein interactions and fusion determinants governing productive hepatocyte invasion. Cold Spring Harb. Perspect. Med. 10, a036830 (2020).
Augestad, E. H. et al. Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity. Sci. Adv. 6, eabb5938 (2020).
Prentoe, J., Velázquez-Moctezuma, R., Foung, S. K., Law, M. & Bukh, J. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. Hepatology 64, 1881â1892 (2016).
Tong, Y., Lavillette, D., Li, Q. & Zhong, J. Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly. Front. Immunol. 9, 1411 (2018).
Law, M. et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat. Med. 14, 25â27 (2008).
Giang, E. et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc. Natl Acad. Sci. USA 109, 6205â6210 (2012).
Yanagi, M., Purcell, R. H., Emerson, S. U. & Bukh, J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl Acad. Sci. USA 94, 8738â8743 (1997).
Meunier, J. C. et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc. Natl Acad. Sci. USA 102, 4560â4565 (2005).
Khan, A. G. et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 509, 381â384 (2014).
Flyak, A. I. et al. HCV broadly neutralizing antibodies use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design. Cell Host Microbe 24, 703â716.e703 (2018).
Tzarum, N. et al. An alternate conformation of HCV E2 neutralizing face as an additional vaccine target. Sci. Adv. 6, eabb5642 (2020).
Tzarum, N. et al. Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies. Sci. Adv. 5, eaav1882 (2019).
Kumar, A. et al. Structural insights into hepatitis C virus receptor binding and entry. Nature 598, 521â525 (2021).
Kumar, A. et al. Regions of hepatitis C virus E2 required for membrane association. Nat. Commun. 14, 433 (2023).
Kong, L. et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science 342, 1090â1094 (2013).
Pfaff-Kilgore, J. M. et al. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Rep. 39, 110859 (2022).
Olesen, C. H., Augestad, E. H., Troise, F., Bukh, J. & Prentoe, J. In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus. PLoS Pathog. 17, e1009720 (2021).
Kong, L. et al. Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. J. Virol. 86, 13085â13088 (2012).
Kong, L. et al. Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc. Natl Acad. Sci. USA 109, 9499â9504 (2012).
Kong, L. et al. Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen. Proc. Natl. Acad Sci. USA 113, 12768â12773 (2016).
Oliver, M. R. et al. Structures of the Hepaci-, Pegi-, and Pestiviruses envelope proteins suggest a novel membrane fusion mechanism. PLoS Biol. 21, e3002174 (2023).
Perin, P. M. et al. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology 63, 49â62 (2016).
Lavillette, D. et al. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81, 8752â8765 (2007).
Catanese, M. T. et al. Ultrastructural analysis of hepatitis C virus particles. Proc. Natl Acad. Sci. USA 110, 9505â9510 (2013).
Rey, F. A. & Lok, S. M. Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell 172, 1319â1334 (2018).
Augestad, E. H., Bukh, J. & Prentoe, J. Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1. Curr. Opin. Virol. 50, 69â75 (2021).
Matsuura, Y. et al. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology 205, 141â150 (1994).
Hu, T., Wu, Z., Wu, S., Chen, S. & Cheng, A. The key amino acids of E protein involved in early flavivirus infection: viral entry. Virol. J. 18, 136 (2021).
Carlsen, T. H., Scheel, T. K., Ramirez, S., Foung, S. K. & Bukh, J. Characterization of hepatitis C virus recombinants with chimeric E1/E2 envelope proteins and identification of single amino acids in the E2 stem region important for entry. J. Virol. 87, 1385â1399 (2013).
Serre, S. B., Krarup, H. B., Bukh, J. & Gottwein, J. M. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance. J .Virol. 87, 12776â12793 (2013).
Prentoe, J. et al. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J. Virol. 88, 1725â1739 (2014).
Dodev, T. S. et al. A tool kit for rapid cloning and expression of recombinant antibodies. Sci. Rep. 4, 5885 (2014).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583â589 (2021).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486â501 (2010).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531â544 (2018).
He, J., Li, T. & Huang, S.-Y. Improvement of cryo-EM maps by simultaneous local and non-local deep learning. Nat. Commun. 14, 3217 (2023).
Williams, C. J. et al. MolProbity: more and better reference data for improved allâatom structure validation. Protein Sci. 27, 293â315 (2018).
DeLano, W. L. Pymol: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82â92 (2002).
Pettersen, E. F. et al. UCSF Chimeraâa visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605â1612 (2004).
Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70â82 (2021).
Yariv, B. et al. Using evolutionary data to make sense of macromolecules with a âface-liftedâ ConSurf. Protein Sci. 32, e4582 (2023).
Rothwangl, K. B., Manicassamy, B., Uprichard, S. L. & Rong, L. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol. J. 5, 46 (2008).
Owsianka, A. M. et al. Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J. Virol. 80, 8695â8704 (2006).
